(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 11.06% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.75%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.3%.
Staar Surgical Co's revenue in 2024 is $322,415,000.On average, 6 Wall Street analysts forecast STAA's revenue for 2024 to be $16,505,084,538, with the lowest STAA revenue forecast at $16,404,762,896, and the highest STAA revenue forecast at $16,609,510,913. On average, 6 Wall Street analysts forecast STAA's revenue for 2025 to be $19,133,922,015, with the lowest STAA revenue forecast at $18,873,466,901, and the highest STAA revenue forecast at $19,707,607,388.
In 2026, STAA is forecast to generate $22,814,988,379 in revenue, with the lowest revenue forecast at $22,134,775,399 and the highest revenue forecast at $23,377,434,600.